Table 5.
Univariate analysis of risk factors associated with ED in patients with PD
| Potential risk factors | Cases with ED (n=116), n (%) | Cases without ED (n=193), n (%) | OR | 95% CI | P |
|---|---|---|---|---|---|
| Coronary artery disease | 9 (7.75) | 3 (1.55) | 5.32 | 1.41–20.10 | 0.013* |
| Dyslipidemia | 23 (19.82) | 15 (7.77) | 2.93 | 1.46–5.89 | 0.002* |
| Diabetes | 13 (11.2) | 10 (5.18) | 2.3 | 0.97–5.45 | 0.056 |
| Hypertension | 31 (26.72) | 33 (17.09) | 1.76 | 1.01–3.08 | 0.044* |
| Obesity | 11 (9.48) | 6 (3.1) | 3.26 | 1.17–9.08 | 0.023* |
| Benign prostatic hyperplasia | 15 (12.9) | 7 (3.6) | 3.94 | 1.55–9.99 | 0.003* |
| Chronic prostatitis | 22 (18.96) | 21 (10.88) | 1.91 | 1.002–3.667 | 0.049* |
| Autoimmune diseases | 10 (8.62) | 6 (3.1) | 2.94 | 1.03–8.31 | 0.042* |
| Dupuytren’s contracture | 4 (3.44) | 5 (2.59) | 1.34 | 0.35–5.1 | 0.665 |
| Low testosterone levels | 3 (2.58) | 2 (1.03) | 2.53 | 0.41–15.4 | 0.312 |
| Penile trauma | 8 (6.89) | 11 (5.69) | 1.22 | 0.47–3.14 | 0.671 |
| Cigarette smoking | 14 (12.06) | 10 (5.1) | 2.51 | 1.07–5.85 | 0.033* |
Note:
*
Statistical significance (P<0.05) compared with non-ED group.
Abbreviations: ED, erectile dysfunction; PD, Peyronie’s disease; OR, odds ratio; CI, confidence interval.